Craft

Stuart Therapeutics

Total Funding

$11 M

Stuart Therapeutics Summary

Company Summary

Overview
Stuart Therapeutics is a biotechnology company that develops a tissue reparative platform for eye diseases. It offers PolyCol, a polypeptide sequence that is designed to repair damaged extracellular matrix (ECM) helical collagen.
Type
Private
Status
Active
Founded
2018
HQ
Stuart, FL, US | view all locations
Website
https://stuarttherapeutics.com
Cybersecurity rating
Sectors

Key People

  • Brian J. Del Buono

    Brian J. Del Buono, EVP, Research and Development

  • Diane Black

    Diane Black, Chairman of Audit Committee

    • Eric Schlumpf

      Eric Schlumpf, President, CEO, Director

    • Walter Flamenbaum

      Walter Flamenbaum, Chairman of Compensation Comittee

      Operating MetricsView all

      Expertise Areas

      3

      May, 2023

      LocationsView all

      1 location detected

      • Stuart, FL HQ

        United States

        411 SE Osceola St #203

      Footer menu